IN2014DN07897A - - Google Patents
Info
- Publication number
- IN2014DN07897A IN2014DN07897A IN7897DEN2014A IN2014DN07897A IN 2014DN07897 A IN2014DN07897 A IN 2014DN07897A IN 7897DEN2014 A IN7897DEN2014 A IN 7897DEN2014A IN 2014DN07897 A IN2014DN07897 A IN 2014DN07897A
- Authority
- IN
- India
- Prior art keywords
- pharmaceutical composition
- controued
- gliclazide
- stabilized
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
- B29C43/003—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor characterised by the choice of material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2001/00—Use of cellulose, modified cellulose or cellulose derivatives, e.g. viscose, as moulding material
- B29K2001/08—Cellulose derivatives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
- B29K2105/0005—Condition, form or state of moulded material or of the material to be shaped containing compounding ingredients
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
- B29K2105/0005—Condition, form or state of moulded material or of the material to be shaped containing compounding ingredients
- B29K2105/0044—Stabilisers, e.g. against oxydation, light or heat
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN7897DEN2014 IN2014DN07897A (ru) | 2012-02-24 | 2013-02-23 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN538DE2012 | 2012-02-24 | ||
PCT/IB2013/051467 WO2013124832A2 (en) | 2012-02-24 | 2013-02-23 | Stabilized controlled-release pharmaceutical composition comprising gliclazide |
IN7897DEN2014 IN2014DN07897A (ru) | 2012-02-24 | 2013-02-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN07897A true IN2014DN07897A (ru) | 2015-04-24 |
Family
ID=49006330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN7897DEN2014 IN2014DN07897A (ru) | 2012-02-24 | 2013-02-23 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20150031737A1 (ru) |
CA (1) | CA2865484A1 (ru) |
IN (1) | IN2014DN07897A (ru) |
WO (1) | WO2013124832A2 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113777207B (zh) * | 2021-09-09 | 2024-06-21 | 安徽省食品药品检验研究院(安徽国家农副加工食品质量监督检验中心) | 一种格列齐特缓释片溶出曲线的测定方法、相似性评价方法及其应用 |
CN115598267B (zh) * | 2022-12-13 | 2023-05-09 | 山东省食品药品检验研究院 | 一种格列齐特中潜在遗传毒性杂质的分析方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996019974A1 (fr) * | 1994-12-27 | 1996-07-04 | Kanebo, Ltd. | Preparation a liberation prolongee |
US6056977A (en) * | 1997-10-15 | 2000-05-02 | Edward Mendell Co., Inc. | Once-a-day controlled release sulfonylurea formulation |
AP1243A (en) | 1999-02-01 | 2004-02-02 | Servier Lab | Core tablet for controlled release of gliclazide after oral administration. |
TW200801513A (en) | 2006-06-29 | 2008-01-01 | Fermiscan Australia Pty Ltd | Improved process |
WO2008062470A2 (en) * | 2006-10-19 | 2008-05-29 | Torrent Pharmaceuticals Limited | Stabilized controlled release dosage form of gliclazide |
-
2013
- 2013-02-23 US US14/380,237 patent/US20150031737A1/en not_active Abandoned
- 2013-02-23 IN IN7897DEN2014 patent/IN2014DN07897A/en unknown
- 2013-02-23 CA CA2865484A patent/CA2865484A1/en not_active Abandoned
- 2013-02-23 WO PCT/IB2013/051467 patent/WO2013124832A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2013124832A2 (en) | 2013-08-29 |
WO2013124832A3 (en) | 2013-11-07 |
CA2865484A1 (en) | 2013-08-29 |
US20150031737A1 (en) | 2015-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016501122A1 (en) | Delayed release compositions of linaclotide | |
TN2015000278A1 (en) | Autotaxin inhibitors | |
GB201118656D0 (en) | New compounds | |
MD20150091A2 (ru) | Противовирусные соединения | |
GB201209613D0 (en) | New compounds | |
IN2014MN00986A (ru) | ||
MX349004B (es) | Nuevos compuestos. | |
PH12015501609A1 (en) | Phenicol antibacterials | |
PH12015501096A1 (en) | Composition for immediate and extended release | |
GEP201706621B (en) | Benzamides | |
EP3034082A4 (en) | Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients | |
MX2014010433A (es) | Nueva forma cristalina de sulfato de sitagliptina. | |
MY165075A (en) | Pharmaceutical composition comprising fimasartan and hydrochlorothiazide | |
EP2931310A4 (en) | COMPOSITIONS, METHODS OF ADMINISTRATION AND USES OF TRIVALENT FORMULATIONS AGAINST DENGUE VIRUS | |
MX2015003034A (es) | Jeringa que contiene una composicion, en particular farmaceutica, que comprende inmunoglobulinas, su metodo de fabricacion y uso. | |
MX2014004210A (es) | Derivados de 2-oxo-piperidinilo. | |
IN2014DN03010A (ru) | ||
IN2014DN07897A (ru) | ||
MX367773B (es) | Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos. | |
IN2012DE00826A (ru) | ||
IN2013CH04314A (ru) | ||
IN2013MU03317A (ru) | ||
WO2014122671A3 (en) | Solid oral compositions of saxagliptin | |
IN2014DN10683A (ru) | ||
IN2013CH04330A (ru) |